Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balance.
Jung
K
K
Friedrich
B
B
Türk
I
I
Roigas
J
J
Lein
M
M
Schnorr
D
D
Loening
S A
SA
D002292:Carcinoma, Renal Cell / Q000201:enzymology*; D002401:Cathepsin B / Q000378:metabolism*; D056655:Cathepsin H; D056668:Cathepsin L; D002403:Cathepsins / Q000378:metabolism*; D003546:Cysteine Endopeptidases / Q000378:metabolism*; D015853:Cysteine Proteinase Inhibitors / Q000378:metabolism*; D010450:Endopeptidases; D004792:Enzyme Precursors / Q000378:metabolism; D006801:Humans; D007680:Kidney Neoplasms / Q000201:enzymology*
D015853:Cysteine Proteinase Inhibitors; D004792:Enzyme Precursors; D002403:Cathepsins; D010450:Endopeptidases; D003546:Cysteine Endopeptidases; D002401:Cathepsin B; C534281:CTSL protein, human; D056668:Cathepsin L; C534126:CTSH protein, human; D056655:Cathepsin H